3min chapter

The HemOnc Pulse cover image

What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?

The HemOnc Pulse

CHAPTER

How to Design a Markov Model to Address Cost-Depactiveness

There is a progression-free survival benefit and some folks might change their practice based on a PFS benefit, so your question is very relevant. Historically for oncology, partition survival models were created. These are very simple models but they aren't able to incorporate a lot of the nuances that we see in lymphoma. A Markov model allows us to create very complex health states. We could create as many health states as we want. It also allows us to calibrate each part of the model using published survival curves.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode